Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Are the Forecasted Growth Rate and Market Size of the High Throughput Screening (HTS) Market?#_x000D_

In the past few years, the peptide and anticoagulant drugs market has witnessed considerable growth. It is projected that the market size will increase from $1.41 billion in 2024 to $1.54 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to the growth during the historic period include increased spending on healthcare, larger investments in healthcare, the rise of market liberalization, a global increase in the number of patients affected by various diseases, and a surge in genetic condition incidents._x000D_

_x000D_

Significant expansion is anticipated in the peptide and anticoagulant drugs market in the coming years. Projected to become a “$2.25 billion industry by 2029,” this market will witness a compound annual growth rate (CAGR) of 9.9%. Factors contributing to this growth include increasing chronic diseases, an aging demographic, rising cancer rates, expanding markets in emerging regions, and a growing incidence of cardiovascular diseases. The forecast period will also see trends like advancements in biotechnology, emergent drug delivery technologies, refined diagnostic approaches, progress in pharmacology, and the advent of new anticoagulant products._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=21252&type=smp_x000D_

_x000D_

#Which Factor Is Shaping The Future Of The High Throughput Screening (HTS) Market?#_x000D_

The escalating prevalence of chronic illnesses is anticipated to spur the expansion of the high-throughput screening (HTS) market. Chronic diseases typically persist for a period of three months or more and require effective long-term management strategies. HTS plays a pivotal role in this process by facilitating the rapid examination of numerous chemical compounds to identify promising drug candidates targeting specific pathways or mechanisms involved in chronic diseases. The National Library of Medicine, a US-based government agency, stated in January 2023 that the number of US citizens aged 50 and above with at least one chronic condition is projected to surge to 142.66 million by 2050. Consequently, the growing prevalence of chronic diseases is likely to stimulate the growth of the high-throughput screening (HTS) market._x000D_

_x000D_

_x000D_

The peptide and anticoagulant drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Hormonal, Antibiotic, Ace Inhibitor, Antifungal, Other Types_x000D_

2) By Route Of Administration: Oral, Injectable, Other Routes Of Administration_x000D_

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels_x000D_

4) By Application: Infectious Diseases, Gynecology, Cancer, Diabetes, Cardiology, Osteoporosis, Other Applications_x000D_

5) By End-users: Hospitals, Specialty Clinics, Homecare, Other End-users_x000D_

_x000D_

Subsegments:_x000D_

1) By Hormonal: Peptide Hormones, Steroid Hormones, Thyroid Hormones, Other Hormones _x000D_

2) By Antibiotic: Beta-Lactams, Macrolides, Tetracyclines, Fluoroquinolones, Other Antibiotics _x000D_

3) By ACE Inhibitor: Captopril, Enalapril, Lisinopril, Ramipril, Other ACE Inhibitors _x000D_

4) By Antifungal: Azoles, Echinocandins, Polyenes, Allylamines, Other Antifungals _x000D_

5) By Other Types: Immunosuppressants, Antineoplastic Agents, Cardiovascular Drugs, Other Peptide And Anticoagulant Drugs _x000D_

_x000D_

#Which Trends Are Redefining The Future Landscape Of The High Throughput Screening (HTS) Industry?#_x000D_

Key players in the peptide and anticoagulant drugs market are concentrating their efforts towards enhancing anticoagulant therapies, like oral anticoagulants, which aim to improve effectiveness, promote patient adherence, and lower the chances of bleeding issues. Oral anticoagulants are drugs consumed orally to avert blood clot formation by suppressing the clotting agents in the blood. For example, in April 2024, Cadrenal Therapeutics Inc., an American pharmaceutical enterprise, was granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for tecarfarin, their cutting-edge oral anticoagulant. This innovative, reversible blood-thinning tecarfarin, is being developed with the intent of minimizing heart attack, stroke, and mortality rates related to blood clots amongst individuals with rare heart disease conditions. The ODD is specifically aimed at preventing thromboembolism and thrombosis in individuals with surgically implanted mechanical circulatory support devices such as left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), ventricular assist devices (VADs), biventricular assist devices, and completely artificial hearts._x000D_

_x000D_

#Which Companies Hold The Largest Market Share In The High Throughput Screening (HTS) Sector?#_x000D_

Major companies operating in the peptide and anticoagulant drugs market are Pfizer Inc., Merck & Co. Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Sanofi S.A., Abbott Laboratories, Novartis AG, Novo Nordisk A/S, Viatris Inc., Baxter International Inc., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Bachem Holding AG, Bharat Serums and Vaccines Limited, Wockhardt Limited, AmbioPharm Inc., MITS Healthcare Private Limited, Siddha Pharmacy, Circle Pharma Inc., Tenwel Pharmaceuticals Pvt. Ltd. _x000D_

_x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/peptide-and-anticoagulant-drugs-global-market-report_x000D_

_x000D_

#How Does Regional Performance Compare Across The High Throughput Screening (HTS) Industry?#_x000D_

North America was the largest region in the peptide and anticoagulant drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide and anticoagulant drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=21252&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model